Edition:
United Kingdom

Aridis Pharmaceuticals Inc (ARDS.OQ)

ARDS.OQ on NASDAQ Stock Exchange Capital Market

6.93USD
3:52pm BST
Change (% chg)

$-0.31 (-4.28%)
Prev Close
$7.24
Open
$7.02
Day's High
$7.02
Day's Low
$6.93
Volume
343
Avg. Vol
1,457
52-wk High
$13.85
52-wk Low
$6.93

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 1.02 -0.995
FY 2018 Dec '18 1.39 -0.670
Sep '18 1.02 -0.976
Jun '18 0.02 -0.242
Mar '18 0.32 -1.033
FY 2017 Dec '17 0.79 -0.724
Sep '17 0.02 -0.786
Jun '17 0.02 -0.860
Mar '17 0.02 -1.108
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 2 0.73 0.75 0.70 --
Quarter Ending Sep-19 3 0.98 1.50 0.70 --
Year Ending Dec-19 4 2.76 4.02 1.02 --
Year Ending Dec-20 4 2.25 3.00 0.00 --
Earnings (per share)
Quarter Ending Jun-19 3 -0.82 -0.61 -1.09 --
Quarter Ending Sep-19 3 -0.66 -0.57 -0.83 --
Year Ending Dec-19 3 -3.06 -2.52 -3.70 --
Year Ending Dec-20 4 -2.80 -2.12 -4.05 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.30 32.55
P/E High - Last 5 Yrs. -- 147.69 48.11
P/E Low - Last 5 Yrs. -- 47.94 23.41
Beta -- 1.08 0.87
Price to Sales (TTM) -- 49.50 8.43
Price to Book (MRQ) -- 10.13 5.27
Price to Tangible Book (MRQ) -- 13.74 6.74
Price to Cash Flow (TTM) -- 56.16 24.12
% Owned Institutions -- 3.71 1.65

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.37
Dividend 5 Year Growth Rate -- 0.78 4.71
Payout Ratio(TTM) -- 7.02 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 206.05 13.45
Sales (TTM) vs TTM 1 Yr. Ago -- 49.05 8.04
Sales - 5 Yr. Growth Rate -- 22.77 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 75.32 48.19
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 11.97 10.46
Capital Spending - 5 Yr. Growth Rate -- 9.11 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.24 2.18
Current Ratio (MRQ) -- 3.57 2.98
LT Debt to Equity (MRQ) -- 18.62 11.35
Total Debt to Equity (MRQ) -- 31.29 16.04
Interest Coverage (TTM) -- -43.11 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.27 52.39
Gross Margin - 5 Yr. Avg. -- 60.50 50.39
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.91 12.41
Operating Margin (TTM) -- -184.93 5.67
Operating Margin - 5 Yr. Avg. -- -127.41 8.00
Pre-Tax Margin (TTM) -- -175.62 4.69
Pre-Tax Margin - 5 Yr. Avg. -- -133.20 8.28
Net Profit Margin (TTM) -- -182.34 1.42
Net Profit Margin - 5 Yr. Avg. -- -137.59 4.69
Effective Tax Rate (TTM) -- 22.46 22.13
Effective Tax Rate - 5 Yr. Avg. -- 15.50 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,653,013 819,627,197
Net Income/Employee (TTM) -- 513,435 92,777,164
Receivable Turnover (TTM) -- 6.28 5.82
Inventory Turnover (TTM) -- 1.89 3.42
Asset Turnover (TTM) -- 0.32 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 6.37 10.65
Return on Assets - 5 Yr. Avg. -- 5.47 11.77
Return on Investment (TTM) -- 8.90 13.82
Return on Investment - 5 Yr. Avg. -- 6.78 15.32
Return on Equity (TTM) -- 10.04 15.24
Return on Equity - 5 Yr. Avg. -- 8.36 16.41

Performance for Aridis Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.73%
# of Holders: 6
Total Shares Held: 59,498
3 Mo. Net Change: 39,575
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 4
# Net Buyers: -2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.